The Obama administration recently awarded a $433 million no-bid contract to Siga Technologies, the maker of ST-246, an experimental smallpox antiviral drug. This staggering amount would have us believe we were dealing with a multi-trillion dollar surplus instead of the mega-deficit of monumental proportions in which we are currently mired.
Recent Comments